TREM2 and Alzheimer disease: On the other hand, other studies have indicated that elevated levels of soluble triggering receptor expressed on myeloid cells 2 (TREM2) and convergence of various anti-inflammatory and pro-inflammatory factors in CSF are predictive of a more gradual clinical deterioration in AD [93,96].